During development, lymphoid stem cells migrate into the thymic rudiment where they differentiate into functionally mature T lymphocytes (1). Among human thymocytes, CD7 + CD2 -CD3 -CD4 -CD8 -(referred hereafter as CD7') cells represent the earliest identifiable step (2-4) . In vitro, these precursors were able to acquire mature T cell antigens (3, 4), but cellular interactions and cytokines necessary for this process are poorly understood. We have previously reported that enriched populations of B lymphocytes from blood produce factors (3, 5) that promote in vitro development of blood-and bone marrow-derived CD7 + CD2 -precursors. Comparing the biochemical characteristics of this B cell-derived activity (3) to known B cell-derived molecules, we found its striking homology to soluble CD23 (sCD23 ; sFcERII) (6, 7) . Using recombinant sCD23 (rsCD23) (7), we then assayed the effect of this molecule alone or with rIL-1 and/or rIL-2 on purified CD7 + thymic precursors . Our results provide direct evidence that sCD23 and rIL-1 synergistically induce CD7 + prothymocytes maturation into CD2'CD3'TCRa//3+ CD4 + and/or CD8 + cells that respond to CD2 triggering and rIL-2.